It is our mission to secure Indiana’s position as a global leader in life sciences by advocating, connecting, promoting, and delivering tangible benefits on behalf of our diverse corporate members.
|
|
MedTech Conference
Boston, MA
October 24-26
Registration Discount Available for IHIF Members
|
|
This month's highlights:
- Introducing New Members
- Member News
- Industry News
- Upcoming Events
- IHIF's Policy Corner
- BIO Business Solutions Featured Vendor
- Member Special Offers
- Become a Member of IHIF
|
|
IHIF members are eligible for discounts and savings on a wide variety of products and services geared towards life sciences companies and general business needs. From lab supplies, waste removal and insurance, to office supplies and credit cards, there is something here for every company. Explore your options and enjoy the benefits of being an IHIF member! |
|
Return visit planned for October
Our partners at the Scottish LifeSciences Association (SLA) are planning a return visit to Indiana this October 4-14. Led by SLA CEO Scott Johnstone, this fall mission will also include representatives from:
-
Sanondaf – Touchless disinfection services. Exploring US market opportunities. Interested in current hospital/health care disinfection practices, market research, strategic partners, equipment distribution.
-
Benenox – Night time sleep aid.
-
Cellexus - We pioneer revolutionary, market leading single-use airlift bioreactor systems and technology.
-
Intuitive Investments Group (IIG) – IIG seeks to provide investors with exposure to a portfolio of investments concentrating on fast growing and/or high potential life sciences businesses operating predominantly in the UK, continental Europe and the US.
RSVP now for the October 6 IHIF Member Reception at IBRI featuring presentations from our Scottish friends!
|
|
NCI SBIR Solicitations
Are you developing an innovative technology to make a difference in the fight against cancer? NCI SBIR is interested in funding small businesses that are working on addressing several cancer technology areas of interest through a set of NIH-defined topics under the FY2023 Contract Solicitation.
To find out if you’re eligible to receive support through this funding mechanism, review the solicitation and this year's NCI SBIR topics:
- Topic 446 - Development of Senotherapeutic Agents for Cancer Treatment
- Topic 447 - Non-invasive Device Technology Research & Development for Chemotherapy-induced Peripheral Neuropathy Management
- Topic 448 - Wearable Devices for Dosimetry of Radiopharmaceutical Therapy
- Topic 449 - Wearable Technologies to Facilitate Remote Monitoring of Cancer Patients Following Treatment
- Topic 450 - Technology Platforms for Circulating Tumor-Macrophage Hybrid Cells
- Topic 451 - Rapid and Affordable Point-of-Care HPV Diagnostics for Cervical Cancer Control
- Topic 452 - Translation of Novel Cancer-Specific Imaging Agents and Techniques to Mediate Successful Image-Guided Cancer Interventions
- Topic 453 - Digital Tools to Integrate Cancer Prevention Within Primary Care
- Topic 454 - Software to Evaluate Artificial Intelligence/Machine Learning Medical Devices in Oncology Settings
|
|
Twelve Indiana businesses are receiving $649,000 as part of Phase I and Phase II matching awards from the state’s Small Business Innovation Research and Small Business Technology Transfer program during the first half of 2022. The SBIR/STTR program is managed by Indianapolis-based Elevate Ventures and the Indiana Economic Development Corp. (Source: Inside Indiana Business, may require subscription)
|
|
The bureau has new recommendations for healthcare organizations to address unpatched medical devices, which it says are increasingly being targeted in cyberattacks.
(Source: Healthcare it news)
|
|
FDA's latest guidance takes a broader approach to cybersecurity, recommending comprehensive risk management programs and documentation consistent with device quality systems.
(Source: BONEZONE)
|
|
Indiana leads the nation in medical data breaches, with more than 80 million records affected since 2009, a new study shows. Much of that was due to one massive incident involving insurance company Anthem Inc. (now called Elevance Health Inc.) in 2015, when hackers obtained data on... More
(Source: Inside Indiana Business, may require subscription)
|
|
The Venture Club of Indiana recently held the 14th annual Innovation Showcase Pitch Competition. Twenty of Indiana’s top startups pitched to more than 350 attendees. Adipo Therapeutics and LaunchCodes tied for first place, joined by Holder in second and Zero Carb LYFE in third place. More
(Source: Inside Indiana Business, may require subscription)
Indianapolis-based health tech startup Olio Health has closed on a $13 million Series A round of funding. The company, which has developed a workflow and collaboration software platform designed to improve post-acute care outcomes for patients, says it plans to use the funding to further product development and make key hires in several departments. More
(Source: Inside Indiana Business, may require subscription)
According to a venture activity report released by Indianapolis-based Elevate Ventures, the Hoosier State is well-positioned for a strong year despite a national slowdown in venture activity in the first half of the year. The 1H 2022 Indiana Venture Report shows Indiana generated 88 deals during the first half of the year, compared to 89 during the same period last year. More
(Source: Inside Indiana Business, may require subscription)
|
|
 |
Welcome New IHIF Members and Strategic Partners! |
|
|
|
Follow IHIF on Twitter to keep up with all of the latest news, events, and exclusive member benefits!
|
Sony DADC is a global supply chain company who has produced billions of discs since 1984 and is based in West Central, Indiana. Sony DADC has demonstrated success in packaging, distribution, injection molding, clean room, EDI solutions, and warehousing. Sony DADC is growing and diversifying business partnerships in each operational area. Sony DADC is ISO Certified/Compliant for ISO 9001, ISO 14001, ISO 27001, and ISO 45001. We demonstrate commitment to our customers through value – added vendor relationships and customer service. At Sony DADC, we have automation, technical expertise and vast engineering know how for your company to grow with correct economy of scale.
|
|
|
|
As a member benefit, IHIF is pleased to share and highlight member company news! Please send press releases to info@ihif.org or tag us on Twitter @IHIF1.
|
|
Need help telling your story?
IHIF is able to provide access to contract/custom press release and writing services. (Fee for service). Inquiries welcome - click here
|
|
|
RoslinCT and Lykan Bioscience Announce the Establishment of a Scientific Advisory Board
Lykan Bioscience and RoslinCT, a leader in Contract Development and Manufacturing for cell therapies, announced the formation of its inaugural Scientific Advisory Board (SAB). The newly created SAB is comprised of cell and gene therapy pioneers with extensive domain experience. The SAB will be working closely with members of the Lykan Bioscience and RoslinCT management and scientific teams, providing valuable insight into a range of topics across the development and manufacturing of advanced therapies.
|
Barnes & Thornburg Expands National Complex Litigation And Life Sciences Practices With New Offices In New Jersey And Philadelphia
Barnes & Thornburg LLP is opening new offices in Northern New Jersey and in Philadelphia, its 21st and 22nd in the U.S. The new offices are anchored by well-respected and nationally recognized product liability, mass tort and life sciences litigators and counselors Michael C. Zogby, Jessica L. Brennan, and Kaitlyn E. Stone in New Jersey, and Chanda A. Miller, Molly E. Flynn, and Rebecca Trela in Philadelphia.
The New Jersey and Philadelphia offices will serve the bustling life sciences, healthcare, consumer products, global manufacturing, financial services, and sophisticated multinational companies that are resident in the corridor. In particular, both New Jersey and Philadelphia are major hubs for biotechnology, pharmaceutical, medical device, diagnostic, research and development, supply chain, medical technology, financial transactions, and investment funds activity.
|
New Med Tech Company, GemViz, Launches In Warsaw
GemViz has announced its launch as the first start-up med-tech company in Warsaw, the Orthopedic Capital of the World.
GemViz is focused on providing services and developing solutions in the rapidly growing digital technology, or med tech, segment of medical devices that will deepen surgical insights and improve patient outcomes.
|
|
|
|
Researchers from Purdue University are receiving a $3 million grant to help the pharmaceutical industry achieve zero waste in its manufacturing operations. The grant, which comes from the National Science Foundation, will enable the team to research alternative, cost-effective solutions to the industry’s current operations. More
(Source: Inside Indiana Business, may require subscription)
|
During fiscal year 2022, 19 technologies developed by faculty were licensed to companies. These licenses were executed through a record-breaking 14 license agreements, exceeding the previous record of 13 set in 2018
(Source: University of Notre Dame IDEA Center)
|
Startup gives IU researchers $1.2M to advance first norovirus vaccine
Norovirus is incredibly common in the U.S. with about 2,500 reported outbreaks each year; the CDC says it’s the number one cause nationally of vomiting and diarrhea for all age groups. But babies and toddlers are especially vulnerable; they’re more likely to have complications that lead to hospitalization or life-threatening dehydration. Scientists have been chasing a vaccine for three decades, but Indiana University researchers say they’ve found a unique solution for babies by piggy-backing on an existing vaccine—and a Boston-based startup is speeding its development with a $1.2 million shot in the arm. Full Story
(Source: IBJ, may require subscription)
|
The Regenstrief Institute in Indianapolis and the schools of medicine and public health at Indiana University are using a five-year grant from the U.S. Centers for Disease Control and Prevention to study the long-term effects of COVID-19. The grant, expected to total $9 million, will fund both the analysis of data from electronic health records and follow individuals over time to detect trends related to what is known as “long COVID.”
Read More (Source: Inside Indiana Business, may require subscription)
|
|
|
|
Italy-based life sciences firm Stevanato Group isn’t expected to open its manufacturing plant in Fishers until 2024, but the company is already expanding its original plan for the facility by hundreds of millions of dollars and 265 workers. Stevanato, which makes drug-containment, drug-delivery and diagnostic products for pharmaceutical and biotech customers, announced plans in June 2021 to spend $145 million to build a 370,000-square-foot facility in Fishers, creating 250 high-wage jobs by the end of 2025. This morning Fishers announced Stevanato had approached the city with a proposal to increase its total investment in the facility to $512 million and its hiring plan to 515 employees by 2031. The Fishers City Council is expected to vote on a new economic development agreement for Stevanato at its next council meeting, on Sept. 19. IBJ’s online team has the details.
(Source: IBJ may require subscription)
|
Kuehne+Nagel North America expands healthcare network with a new distribution center
Kuehne+Nagel solidifies Indianapolis as a key location for further healthcare contract logistics development
Multi-client GDP facility to meet customer needs
Expansion comes on the heels of similar expansions in Memphis (TN) and Southaven (MS)
|
|
Ascension St. Vincent Hospital in Indianapolis has earned The Joint Commission’s Gold Seal of Approval and Certification for brain tumor care, making it the first in Indiana to do so. The hospital says it is also now the sixth center in the U.S. to earn brain tumor certification. More (Source: IBJ may require subscription)
|
Startup awarded nearly $1M to advance diabetes drug
(Source: Inside Indiana Business, May require subscription)
|
|
What We're Following at Home and on the Hill
|
|
IHIF Actions:
- Participated in direct outreach to Indiana legislators opposing drug pricing provisions in the reconciliation package
-
Continued support for rapid reauthorization of the SBIR/STTR programs.
- Watching: Indiana Legislature Summer Study Committees
|
|
The Indiana Health Industry Forum provides guidance and leadership on public policy issues that contribute to innovation in the health science sector, deliver therapies to patients in need, and further the development and growth of our member companies. IHIF works at the federal and state level and partners with several other organizations and groups to support specific initiatives and legislation.
|
|
Lilly CEO warns effects of Inflation Reduction Act will ripple through biopharma ecosystem
Drug pricing provisions of the Inflation Reduction Act have fundamentally changed the economics of the biopharma industry, according to David Ricks, chair and CEO of Eli Lilly.
In an interview with BioCentury, Ricks said he and his peers consider the drug price regulation to be equivalent to a loss of exclusivity event. The value of most small molecule therapies has been cut by at least 50%, Ricks told BioCentury. This will force pharmas to abandon some small molecule programs, reduce the amounts they are willing to pay for assets from biotechs, and lead investors to abandon some deals that would have been viable before President Joe Biden signed the IRA into law, Ricks said.
BioCentury Washington Editor Steve Usdin’s story is the first in a series exploring the impact of the new law on the innovation ecosystem.
Read More (Source: BioCentury - Registration or subscription required)
|
|
Good Day BIO: Biden's EO on biotech and biomanufacturing
President Biden yesterday signed an executive order directing a “whole-of-government approach to advance biotechnology and biomanufacturing.”
The order takes several positive steps: coordinating federal R&D funding, streamlining regulation to facilitate development, establishing a data initiative to support research, expanding market opportunities for bioenergy and biobased products and services, and supporting the training of biotech specialists.
Read More - (Source: Good Day Bio ,September 13)
|
|
SBIR/STTR Reauthorization Update
We are pleased to report that SBIR/STTR reauthorization legislation passed the Senate last week and is set for a vote in the House of Representatives on September 28, where it is expected to pass. IHIF would like to thank everyone who took action and spoke out in favor of reauthorization of this critical program for small businesses. We would still particularly like to share two excellent op-ed pieces by Dr. Sherine Adbelmawla and Dr. Paul Dreier (following).
|
|
Two federal programs that support innovations and small businesses are in danger of disappearing unless Congress acts by Sept. 30
By Dr. Sherine Abdelmawla, co-founder and Chief Executive Officer, Akanocure Pharmaceuticals, Inc.
The Small Business Innovation Research (SBIR) and the Small Business Technology Transfer (STTR) are two federal programs that were established 40 years ago to enable U.S. small-business innovation. The programs help academic and industry scientists commercialize their inventions by providing early-stage funding. The programs also aim to increase the participation of minorities and socially and economically disadvantaged individuals in entrepreneurship and to satisfy federal R&D needs through engaging small businesses. Full Story(Source: Inside Indiana Business, may require subscription)
|
|
Dr. Paul Dreier, CEO, Novilytic
The chief executive officer of West Lafayette-based startup Novilytic says the potential expiration of the federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs would have a major impact on innovation in Indiana. Congress has until September 30 to reauthorize the programs, which provide billions of dollars in funding each year. “It’s going to put us and America behind,” said Paul Dreier. “We need this type of funding to grow our country and to keep a technology leadership on a global scale.”
LISTEN: In an interview with Inside INdiana Business Reporter Alex Brown, Dreier said many businesses rely on SBIR/STTR funding. More(Source: Inside Indiana Business, may require subscription)
|
|
The FDA's reliance on pharmaceutical companies to fund about 75% of its drug division's budget through user fees has drawn criticism from some patients and providers who say the arrangement creates a potential conflict of interest. Congress is expected to reauthorize the multibillion-dollar program by Sept. 30.
|
|
Op/Ed: PASTEUR Act is a game-changer in effort to combat antibiotic-resistant superbugs
by: Haley Pritchard
People in Indiana, across the country and around the world are facing a growing threat to their health from "superbugs," bacterial and fungal infections that are resistant to existing antibiotics and antimicrobial drugs.
We're facing a nightmarish scenario that's getting worse. Superbugs are continuously evolving ― and faster than scientists are inventing new treatments.
|
|
Special Offers for IHIF Members |
|
|
Lab-Crafters showcases our I-FLEX System, showing you all it can do. It truly allows for quick change as your lab requirements change.
This animated video will take you through all the features of an individual bench.
Please reach out to Betsy Fouts with any questions, suggestions, or comments.
|
|
|
|
OpenTrons – Laboratory Automation Solutions
Promotional Offer for IHIF Members: FREE pipette with OT-2 robot order!
Introducing the OT-2, your personal pipetting robot.
|
|
|
|
The MedTech Conference
Boston, MA - October 24-26, 2022
The MedTech Conference is poised to make its momentous return in Boston, MA from October 24-26, 2022! After two years of virtual conferences, come gather with more than 3,000 of the world's top medtech executives for three days of networking, education and inspiration. Featuring more than 100 sessions led by dynamic speakers, over 150 exhibitors from around the world, and the newly launched Investor Forum, this year's Conference is a can't-miss event. Visit our website to learn more and register: https://themedtechconference.com/
IHIF Members take 10% off your registration using promo code SPO22
|
|
BIO International Convention 2023 Now Accepting Call for Sessions Proposals
Programming is an integral part of the success of the BIO International Convention and we need your support to bring the most engaging conversations to the table as we look to define the experience at BIO 2023 in Boston, MA, June 5-8. As a valued change-maker in the biotech community, we're inviting you to shape our program by submitting a proposal for this year's Call for Sessions.
Key Program Themes Include:
· Therapeutic Frontiers – innovations and explorations with an emphasis on oncology, neurology, diagnostics, and applications of AI to speed R&D
· The Business of Biotech – in a tough investment climate, share the latest trends in capital formation, deal-making, and partnering
· Regulatory and Policy Outlook – from local to global, we’re looking for expert-led sessions that share the promises and potential pitfalls for companies at every stage of development
· Human Capital – with special emphasis on the benefits of a thoughtful DEI strategy and growing the biotech workforce of the future
The deadline for submitting a proposal is October 6th, 2022, so don't miss out on the opportunity to be a part of the world's largest biotechnology industry event!
|
|
McCloskey Round 1 Submissions Due
Tue. Oct 25, 2022 | Submission Deadline
This is the final day to submit your application for round one of the McCloskey New Venture Competition. All submissions must be on the submittable platform by 5:00 PM.
|
|
2022 - 2023
Indiana Life Sciences
Collaboration Conference Series
Hosted by the Kelley School’s Center for the Business of Life Sciences, the Nov. 18 conference in Indianapolis will examine recent advancements, such as the development of mRNA vaccines, radiopharmaceuticals and gene therapies, and Indiana’s role in that innovation.
Upcoming Topics
November 18, 2022
February 24, 2023
April 28, 2023
|
|
BioCom Global Life Science Partnering Conference - Registration Open
FEBRUARY 28TH TO MARCH 2ND, 2023
THE LODGE AT TORREY PINES | SAN DIEGO, CA
This conference is an exclusive global partnering forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. Join us next February 2023, where industry leaders will debate current trends, companies will showcase their latest technologies and all attendees will have the opportunity to schedule one-on-one meetings with leading deal-makers from around the globe.
The partnering conference and the relationships you build promise to be fruitful for your business ventures this year and for many years to come. We are excited by the prospect of continuing an annual bio-pharma partnering conference that brings together leading deal makers and emerging biotechs from around the world.
|
|
Eiteljorg Museum Plans Scottish Exhibition
One of the interesting conversations that came out of the SLA visit in May was a connection to an upcoming exhibition at the Eiteljorg Museum of Native American Art in Indianapolis. In August 2023, the museum will feature the works of Alfred Jacob Miller - a Scottish landscape artist who sketched and painted scenes of the American West on behalf of his patron, Sir William Drummond Stewart. Originally displayed in Murthly Castle in Perthshire, Scotland, the collection has been reassembled and will be displayed as it would have appeared to Sir Stewart. The paintings show details of the Rendezvous - an important trading event for Native Americans, trappers, traders, and inhabitants of the American West in the 1800s. For more information on the exhibit or if you might have an interest in becoming a corporate sponsor, please learn more. IHIF and SLA are excited to help support this fascinating cultural connection! Learn More: Alfred Jacob Miller: Revisiting the Rendezvous in Scotland and Today
|
|
BIO Business Solutions - Special Discounts for IHIF Members |
|
BIO Business Solutions provides cost-savings offers to eligible IHIF Members. To learn more about the programs and services available, please click here. Not an IHIF member? Join today!
|
|
Featured Program
Please share with someone in your company who would find this helpful
|
|
ALT is a full-service provider of premium refurbished lab equipment and surplus strategy services for the life sciences. With more than 6,000 instruments in stock ranging from small benchtop accessories to robust triple quad mass spectrometers – all items are carefully refurbished and delivered with a one-year warranty. ALT also purchases, consigns, trades, or auctions your surplus equipment to monetize your assets and maximize your ROI. |
|
IHIF Member Benefits
Equipment Purchase Benefits:
- Free one-year equipment warranty
- Minimum 15% no-hassle discount on list price*
- Minimum 10% additional discount on sale items*
- Up to 10% discount on all Agilent Certified Pre-Owned products
*Agilent factory-refurbished equipment excluded
Surplus Strategy Services:
- Double Credit Offer (2X ALT's Cash Offer)
- Up to 10% discount on equipment and asset appraisal services
- Up to 10% rebate on buyer's premium
- 10% bonus on standard consignment split
- Enhanced Consignment program featuring a 5% increase in split
- Discounted or waived project expenses
|
|
Join IHIF - Become a Member Today! |
|
About IHIF Membership
Now is a great time to become a member of the Indiana Health Industry Forum! Join your voice to over 150 current member companies to impact the strategic direction of Indiana's health science sector.
Membership in IHIF offers a number of solutions:
- Promote your business, locally, nationally, and globally.
- Support the industry in the state and contribute directly to its growth and direction.
- Find others who share your interests and build your business network.
- Lend your voice to public policies that support innovation.
- Directly impact your bottom line with significant savings and discount programs exclusively for IHIF members.
To complete a membership application, click here.
|
|
|
|
|
|
|
